Revolutionary Advanced Injectable Mesotherapy

NCTF® Boost 135 HA

hydrate, revitalise, treat fine lines and wrinkles, dry crepey skin, under-eye dark circles, necklines, and perioral lines.

What is NCTF® Boost 135 HA?

NCTF® Boost 135 HA is a non-surgical cosmetic treatment that involves injecting a combination of hyaluronic acid and has a unique anti-ageing cocktail of 59 ingredients: hyaluronic acid, 12 vitamins, 24 amino acids, 6 co-enzymes, nucleic acids, 6 minerals and others.This treatment is designed to hydrate, revitalize and rejuvenate the skin, leaving you with a fresher, younger-looking appearance.

NCTF® Boost 135 HA is a polyrevitalizing complex that nourishes the epidermis by providing the ingredients that it needs to thrive. The treatment creates the optimal environment for fibroblasts, which are responsible for the production of collagen, elastin and hyaluronic acid.

Why choose NCTF® Boost 135 HA?

There are many reasons why NCTF® Boost 135 HA is the perfect choice for those looking to improve their skin's appearance. Firstly, this treatment is non-invasive and requires no downtime, meaning you can resume your daily activities immediately after treatment. Additionally, the hyaluronic acid used in the treatment helps to boost skin hydration, while the vitamins and amino acids help to stimulate collagen and elastin production, resulting in smoother, firmer skin.

Pre & Post Care

Who is a suitable candidate for NCTF® Boost 135 HA?

NCTF® Boost 135 HA is suitable for individuals of all ages and skin types who want to improve the appearance of their skin. This treatment is particularly beneficial for those with dull, dehydrated skin, fine lines and wrinkles, dark under-eye circles, necklines, and uneven skin tone and texture.

·       Prevention of wrinkles.
·       For radiance, elasticity & hydration.
·       Anti-ageing solution.
·       Tone & boosting of tired-looking skin.
· Improvement in pore size.
·       Face, Neck, Hands & Décolletage.

What can I expect during the treatment?

During the treatment, a series of injections will be made into the skin using a fine needle. The treatment is coupled with a cleanse and a light peel to hydrate and plump the skin. The procedure is generally well-tolerated, with most patients experiencing little to no discomfort. The entire treatment usually takes between 30 and 45 minutes, depending on the size of the treatment area.

You should not have NCTF® boost 135 HA if you are pregnant or breastfeeding and you should defer treatment if you have any active infections, skin disorders, immune disorders, or are taking blood thinning medication. Advise us if you are taking any medications, have allergies, or get cold sores.

As with any injectable treatment, we recommend avoiding excessive alcohol consumption and high intensity exercise 24 hours prior to your treatment to reduce the risk of bruising.

Immediately after the treatment, there may be redness, swelling, bruising or rarely you may notice tiny bumps due to the intense build-up of moisture underneath the skin. All these side effects are temporary and will settle after one to two days.

Book appointment

how to treat dark circles under the eyes

What causes dark circles under the eyes?

The Sublime Approach

Before any treatment commences an initial consultation is required. This is an hour appointment that costs $50, this will be deducted from your total should you go ahead with a procedure within 2 weeks of consult.
Antiwrinkle treatment can be included in this time. Your medical history and skin concerns will be assessed. It is an opportunity for your questions to be answered. Together we discuss a suitable treatment plan. You are under no obligations to undergo treatment then and there, you may wish to have a think about it first, and book in for treatment later.

Pricing

Per Treatment

$450

Disclaimer

*Cosmetic treatments are a prescription medicine. For treatment risks and benefits please visit http://medsafe.govt.nz/ for further information. Individual results may vary.

Juvederm

IMPORTANT INFORMATION: The JUVÉDERM® range of injectable gels are medical devices for use in adults. JUVÉDERM® VOLITE contain 12mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL. JUVÉDERM® ULTRA XC and JUVÉDERM® ULTRA PLUS XC contain 24mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL. Juvéderm® VOLITE™ is for filling superficial depressions of the skin as well as for additional improvement of skin quality attributes such as hydration and elasticity. JUVÉDERM® ULTRA XC is for filling medium-sized depressions of the skin as well as for lip definition. JUVÉDERM® ULTRA PLUS XC is for filling mid and/or deep depressions of the skin as well as for lip definition and enhancement. All JUVÉDERM® products should be administered only by a trained medical professional. JUVÉDERM® ULTRA XC and JUVÉDERM® ULTRA PLUS XC™ should not be injected into the eyelids. You should not receive treatment with any JUVÉDERM® product if you are below 18 years of age, have untreated epilepsy, history of hypertrophic scars or porphyria, or if you are pregnant or breastfeeding, hypersensitivity to ingredients including hyaluronic acid, lidocaine or amide-type local anaesthetics, any areas of cutaneous inflammation and/or infections, or if you have just had laser treatment, deep chemical peel or dermabrasion. Precautions: Caution is required if you have received treatment with another dermal filler; if you have a history of or are currently suffering an auto-immune disease, severe multiple allergies, anaphylactic shock, streptococcal disease, symptoms of cardiac conduction disorders; or if you are taking certain medications including anti-coagulants or certain drugs that reduce/inhibit hepatic metabolism. Avoid makeup for 12 hours after injection and prolonged exposure to sunlight/UV light/extreme temperatures for 2 weeks. Adverse effects reported after treatment with JUVÉDERM® range of fillers have included immediate or delayed injection site inflammatory reactions (redness/swelling/ itching/pain on pressure) persisting a week post treatment, haematomas, induration or nodules, discolouration, weak filling effect, risk of infection, abscess formation, granuloma, necrosis or hypersensitivity. Please ask your medical professional or request for the Directions For Use for complete list of precautions and adverse effects per respective filler. JUVÉDERM® injectable gels are not funded on the New Zealand Pharmaceutical Scheme. You will need to pay for this treatment. Normal visit fees apply. Speak to your medical professional about your own situation and about the benefits/ risks of this procedure in appearance medicine. If you have any side effects or concerns speak to your doctor. ®Trademark(s) and registered trademark(s) of Allergan, Inc. Allergan Australia Pty Ltd. 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. © 2018 Allergan. All rights reserved. Date of preparation: October 2018 ANZ/0104/2017.

Restylane

IMPORTANT INFORMATION: Restylane is an unfunded Treatment that you pay for. Ask your Doctor if Restylane is right for you. Normal Doctors charges apply. Restylane is an injectable intradermal implant containing Hyaluronic acid, stabilized 20 mg/ml. Restylane is used for facial tissue augmentation and lip enhancement. Restylane should only be injected by a medical professional. Tell your medical professional if you have a bleeding disorder or if you are being treated with blood thinning medicines, or any other medicines you are taking. Precautions: Allergy to Hyaluronic acid or any active ingredients. Restylane should not be used where there is active skin disease, inflammation or related conditions. Do not use if pregnant or breastfeeding, or in children. Avoid intense heat or cold after treatment until swelling and redness have resolved. Side effects: common injection-related reactions might occur, including redness, swelling, pain, itching, bruising, tenderness or lumpiness at the implant site. Typically, these resolve in a few days to a week. Tell your medical professional if you experience any side effects. For further information ask your medical professional. Q-Med c/o Pharmacy Retailing (NZ) t/a Healthcare Logistics, Auckland 0800 174 104.

Teoxane

IMPORTANT INFORMATION: TEOSYAL RHA® 2, TEOSYAL RHA® 3, TEOSYAL RHA® 4, TEOSYAL® PURESENSE REDENSITY 2, and TEOSYAL® PURESENSE ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anaesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents, we recommend not use lidocaine-containing products and please refer to products without lidocaine. They are class III medical device and are regulated health product bearing the CE marking (CE2797) under this regulation.

Local manifestations: inflammatory reactions (erythema, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, dyschromia, abscesses, indurations, nodules (possibly granulomas). General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant. Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke.

Please consult your physician or pharmacist for more information. Please refer to instructions for use

Stylage

Stylage S Lidocaine (16mg/mL), Stylage M Lidocaine™ (20mg/mL), Stylage L Lidocaine™(24mg/mL), Stylage XL Lidocaine™(26mg/mL), Stylage XXL™(21mg/mL), are medical devices Class III for the filling of medium size and deep facial wrinkles by injection into the skin and for creating definition and volume in the lips. Contains transparent cross-linked sodium hyaluronate gel of non-animal origin with lidocaine 0.3% to reduce local pain. Cautions: people with autoimmune disease, or who are pregnant, breastfeeding, under 18 years of age or have an increased susceptibility to keloid formation and hypertrophic scarring. People on blood thinning medicines. Possible side effects: injection site inflammatory reactions (redness/swelling, itching/pain on pressure) induration or nodules; discolouration. You will need to pay for this product and doctor’s fees apply. If you have side effects or concerns speak to your practitioner. Distributed by EnVogue Skin NZ Pty Ltd

Fillmed

ART FILLER® Fine Lines: Fill in fine lines, superficial lines and small skin folds of crow’s feet, forehead, upper lip and cheeks; ART FILLER® Volume: Restore volume to the mid-face, jawline and temples; ART FILLER® Universal, ART FILLER® Lips and ART FILLER® Lips Soft: Fill medium and deep nasolabial folds with or without marionette lines dermis, increase the volume of lip and enhance the lip outline. Class III medical devices (CE0123). NCTF® 135HA is an anti-ageing injectable product indicated for intense revitalization and hydration of tired or dull skin, filling of superficial wrinkles and redensification of mature or slack skin. Class III medical devices (CE0297). M-HA®10 is a visco-elastic solution aimed at restoring the loss of hyaluronic acid due to skin ageing. It is designed to be injected into the upper dermis to improve the hydration, radiance and elasticity of the skin and to serve as a filling agent for small wrinkles such as crow’s feet, laughter lines or lines around the mouth caused by smoking. Class III medical devices (CE0297). M-HA® 18:The device is a viscoelastic solution to replenish the loss of hyaluronic acid due to ageing, to maintain hydration, to improve tone and elasticity of the skin and to act as a filler for small lines such as crow’s feet, smile lines or smoke lines surrounding the mouth. It is indicated to be injected into the superficial dermal tissue. Manufacturer: CROMA GmbH. Class III medical devices (CE0123). BIONUTRILIFT® cannulas: Device intended for the injection of dermal fillers. Manufacturer: Soft Medical Aesthetics. Class IIa medical devices (CE0459). NANOSOFT: indicated for intradermal injection by microneedles. Manufacturer: NanoPass Technologies Ltd. Class IIa medical devices (0344). These medical devices are regulated health products that bear the CE mark under this regulation. A treatment with a filling product may require several touch-ups over time to achieve the desired correction. The use of these products requires the intervention of a health professional, ask your doctor for advice. Treatment with medical devices can have undesirable effects.